BOLGER JOHN C 4
4 · Fulgent Genetics, Inc. · Filed Jun 2, 2022
Insider Transaction Report
Form 4
BOLGER JOHN C
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-05-31−313→ 0 totalExercise: $3.92Exp: 2028-05-18→ Common Stock (313 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-31−313→ 1,250 totalExercise: $5.81Exp: 2029-05-30→ Common Stock (313 underlying) - Exercise/Conversion
Common Stock
2022-05-31$3.92/sh+313$1,229→ 4,313 total - Exercise/Conversion
Common Stock
2022-05-31$5.81/sh+313$1,818→ 4,313 total - Sale
Common Stock
2022-05-31$55.25/sh−500$27,625→ 3,500 total - Sale
Common Stock
2022-05-31$55.32/sh−313$17,315→ 4,000 total - Sale
Common Stock
2022-05-31$55.44/sh−313$17,351→ 4,000 total
Footnotes (2)
- [F1]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months, subject to the reporting person's continued service for the Issuer on each vesting date.
- [F2]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months, subject to the reporting person's continued service for the Issuer on each vesting date.